Abstract
Introduction Around 885,000 people live with dementia in the UK of which around 50% experience a fall each year. ‘Keep On Keep Up’ (KOKU) is an NHS approved gamified, digital health program designed to maintain function and reduce falls through strength & balance exercises (FaME/OTAGO), and health literacy games. KOKU has been adapted to the needs of people living with Dementia (PLwD) in the community, known as KOKU-LITE. This trial aims to test the feasibility and acceptability of trial processes and usability of KOKU-LITE.
Methods and analysis A two-arm, mixed methods, feasibility randomised controlled trial will be conducted. Participants aged ≥55 years meeting the eligibility criteria will be recruited from patient organisations across Greater Manchester, UK. Participants randomised into the intervention arm will receive 6 weeks KOKU-LITE program plus dementia specific falls prevention leaflet and participants randomised into the control arm will receive dementia specific falls prevention leaflet. Outcome measures include: recruitment rate, adherence, quality of life, participants’ Activities of Daily Living, physical activity levels, functional ability, lower limb strength, fear of falling, falls risk, mood, and user’s experience of the technology. Post-intervention interviews or focus groups with participants and health and social care professionals will explore feasibility of trial processes & technology and evaluate the usability and acceptability of the intervention respectively. Analyses will be descriptive.
Ethics and dissemination This feasibility trial has been reviewed and received favourable ethical approval from Yorkshire & The Humber - Bradford Leeds Research Ethics Committee, Newcastle upon Tyne (REC reference 23/YH/0262). The findings of the study will be disseminated through peer-reviewed scientific journals, at conferences, publication on University of Manchester, Applied Research Collaboration Greater Manchester (ARC-GM) and KOKU websites.
Trial registration number NCT06149702
Strengths and Limitations of this study
This is one of the first studies to test the feasibility and acceptability of trial processes and usability of a gamified digital health program for falls prevention and to improve well-being in people living with dementia in the community known as KOKU-LITE.
Recruiting and retaining people living with dementia can be very challenging and therefore this feasibility study will explore and evaluate different strategies to recruit participants and estimate the time required for recruitment.
The barriers and facilitators identified in the recruitment and retention phase of the trial will help us to design a robust definitive trial.
We have involved people with lived experience of dementia extensively in the development of KOKU-LITE and will continue to do so in feasibility testing of KOKU-LITE to inform a larger study that will test effectiveness.
This is a feasibility trial and is not powered to determine the effectiveness of the intervention.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
NCT06149702
Funding Statement
This work is supported by the National Institute of Health Research (NIHR) and Alzheimers Society (award number NIHR200174).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This feasibility trial has been reviewed and received favourable ethical approval from Yorkshire & The Humber - Bradford Leeds Research Ethics Committee, Newcastle upon Tyne (REC reference 23/YH/0262).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
At the end of the project, we will deposit a fully anonymised dataset in an open data repository - Figshare at the University of Manchester Library, as well as by request from the primary and corresponding author on reasonable request.
